semaglutide우선순위 낮음근거 검토기타
LITERATURE DETAIL · PMID 42604899
Beyond Small Molecules: Applying Fragment Molecular Orbital Sygnature Platform (FMO-SP) to Emerging Modalities.
Beyond Small Molecules: Applying Fragment Molecular Orbital Sygnature Platform (FMO-SP) to Emerging Modalities.
- 저자
- Alexander Heifetz, Girinath G Pillai, Maryamdokht Taimoory, Louise Birch, Colin Sambrook Smith
- 저널
- Methods in molecular biology (Clifton, N.J.)
- 공개일
- 2026
- 연구 유형
- 기타
- DOI
- 10.1007/978-1-0716-5420-0_6
문헌 요약
Drug discovery is rapidly expanding beyond traditional small molecules to encompass new therapeutic modalities capable of addressing previously "undruggable" targets. Between 2015 and mid-2025, FDA approvals increasingly included biologics and emerging therapeutic modalities such as antibody-drug conjugates (ADCs), nucleic acid therapeutics, and other non…
PV 검토 포인트
누적 안전성 근거로 분류하고 기존 시그널과의 일관성을 확인합니다.